Application of pixel truncation to reduce intensity artifacts in myocardial SPECT imaging with Tc-99m tetrofosmin

Journal of Nuclear Cardiology

Volumn 9, Issue 6, 2002, Pages 622-631

  Funahashi, Masao ^a   Shimonagata, Tsuyoshi ^a   Mihara, Kazuhiro ^b   Kashiyama, Kazuyuki ^a   Shimizu, Ryuichi ^a   Machida, Shuzo ^a   Izumi, Kazuyuki ^a   Kusuoka, Hideo ^c   Nishimura, Tsunehiko ^d   Hoki, Noritake ^a   Kawamoto, Sei Ichi ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c Department of Radiology   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Intensity artifacts; Pixel truncation; Technetium 99m tetrofosmin

Indexed keywords

TETROFOSMIN TC 99M;

ARTICLE; ARTIFACT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ERROR; GALLBLADDER; HEART MUSCLE; HEART MUSCLE PERFUSION; IMAGING SYSTEM; PRIORITY JOURNAL; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0036868703     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.126682     Document Type: Article

References (16)

1. Kelly JD, Foster AM, Highly B, Archer CM, Booker FS, Canning LR, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-7.
2. Jain D, Wacker FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254-9.
3. Nakajima K, Taki J, Shuke N, Bunko H, Tanaka S, Hisada K. Myocardial perfusion imaging dynamic analysis with technetium-99m-tetrofosmin. J Nucl Med 1993;34:1478-84.
4. 201T1 imaging and coronary angiography in a phase III multicenter trial. Circulation 1995;91:313-9.
5. O'Conner MK, Kelly BJ. Evaluation of techniques for elimination of hot bladder artifacts in SPECT of the pelvis. J Nucl Med 1990;31:1872-5.
6. Eisner R, Churchwell A, Noever T, Nowak D, Cloninger K, Dunn D, Churchwell A, et al. Quantitative analysis of the tomographic thallium-201 myocardial bull's eye display: critical role of correcting for patient motion. J Nucl Med 1988;29:91-7.
7. Friedman J, Train KV, Maddahi J, Rozanski A, Prigent F, Bietendorf J, et al. "Upward creep" of the heart: a frequent source of false-positive reversible defects during thallium-201 stress-redistribution SPECT. J Nucl Med 1989;30:1718-22.
8. Nakajima K, Shuke N, Taki J, Ichihara T, Motomura N, Bunko H, et al. A simulation of dynamic SPECT using radiopharmaceuticals with rapid clearance. J Nucl Med 1992;33:1200-6.
9. Sorenson J, Phelps M. Physics in nuclear medicine. 2nd ed. Orlando: Grune and Stratton; 1987. p. 394-401.
10. King MA, Xia W, deVries DJ, Pan T, Villegas BJ, Dahlberg S, et al. A Monte Carlo investigation of artifacts caused by liver uptake in single-photon emission computed tomography perfusion imaging with technetium 99m-labeled agents. J Nucl Cardiol 1996;3:18-29.
11. Nuyts J, Dupont P, Van den Maegdenbergh V, Vleugels S, Suetens P, Mortelmans L. A study of liver-heart artifact in emission tomography. J Nucl Med 1995;36:133-9.
12. Bok B, Bice A, Clausen M, Wong D, Wahner H. Artifacts in camera based single photon emission tomography due to time activity variation. Eur J Nucl Med 1987;13:439-42.
13. Gillen G, McKillop J, Hilditch T, Davidson J, Elliot A. Digital filtering of the bladder in SPECT bone studies of the pelvis. J Nucl Med 1988;29:1587-95.
14. Bunker SR, Torre DM, Scmidt WP, Handmarker H. Bladder artifact correction for SPECT evaluation of the hips [abstract]. J Nucl Med 1988;29:780.
15. Bunker SR, Handmarker H, Torre DM, Scmidt WP. Pixel overflow artifacts in SPECT evaluation of the skeleton. Radiology 1990;174:229-32.
16. O'Connor MK, Caiati C, Christian TF, Gibbons RJ. Effects of scatter correction on the measurement of infract size from SPECT cardiac phantom studies. J Nucl Med 1995;36:2080-6.